Salt Lake City, UT, United States of America

Andrew Thliveris


Average Co-Inventor Count = 12.0

ph-index = 7

Forward Citations = 400(Granted Patents)


Company Filing History:


Years Active: 1994-2009

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Andrew Thliveris

Introduction

Andrew Thliveris is a prominent inventor based in Salt Lake City, UT, known for his significant contributions to the field of genetic research and diagnostics. With a total of seven patents to his name, Thliveris has focused extensively on the APC gene, providing valuable tools and methods for assessing genetic mutations.

Latest Patents

Among his latest inventions are patents related to APC antibodies. These patents disclose a human gene termed APC, along with methods and kits designed for assessing mutations of the APC gene in human tissues and bodily samples. Particularly, APC mutations are prevalent among patients with familial adenomatous polyposis as well as those with sporadic colorectal cancer. The expression of the APC gene in most normal tissues supports the notion that it functions as a tumor suppressor. Furthermore, the diagnosis for mutant APC by immunoassay further enhances the capabilities for detecting these mutations, contributing to early diagnosis and better management of related diseases.

Career Highlights

Andrew Thliveris has had a fruitful career, contributing to several prestigious institutions. Notable among them are The Johns Hopkins University and the University of Utah Research Foundation, where he honed his skills and expanded his research in genetics and diagnostics.

Collaborations

Throughout his career, Thliveris has collaborated with esteemed colleagues such as Hans Albertsen and Rakesh Anand. These partnerships have facilitated innovation and have played a key role in the advancement of research in human genetics.

Conclusion

In conclusion, Andrew Thliveris has made significant strides in the field of genetic research, particularly through his work on the APC gene. With a strong portfolio of patents and collaborations with leading institutions and individuals, he continues to impact the way we understand and diagnose colorectal cancer and related conditions. His contributions exemplify the essence of innovation within the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…